← Leaderboards
Neeraj Agarwal
University Of Utah
$1,018,367
Attributed
$2,036,734
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $692.9K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$2,036,734 · 1
By mechanism
R01$2,036,734 · 1
Top collaborators
- Adriana Coletta3 shared
Most similar at University Of Utah
Same institution · by research overlap
- Paul C Lastayo$3,232,233
- Young-Hoon Sung$1,493,730
- Markus Amann$6,060,766
- Robert E Shaddy$2,067,737
- Srinivasan Beddhu$13,920,703
Others in their field
Other Rising Stars on “Adopted”
- Richard Smith · Medical Device Innovation Consortium$41,401,350
- Cathie Snyder · Rho Federal Systems Division, Inc.$13,500,724
- Jason Dickens · Duke University$12,259,409
- Kari A Stephens · University Of Washington$9,782,581
- Peter N. Schmidt · Rho Federal Systems Division, Inc.$8,977,742
- Elizabeth Kilgore · Icf, Inc., Llc$8,942,190
Research focus
AdoptedAdvanced Malignant NeoplasmAnalogAndrogen Deprivation TherapyAndrogensAnti-CancerAttenuatedCancer BiomarkersCancer SurvivalCancer SurvivorshipCancer TherapyCaringCastrate Sensitive Prostate CancerCell Free DnaChemotherapyColorectal CancerComplementCreatineDouble-Blind MethodDouble-Blind Placebo Controlled TrialDual-Energy X-Ray AbsorptiometryEducational InterventionEffectivenessAdherence
Grant awards (3)
Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression: A double-blind randomized controlled trial$692,911
R01 · FY2025 · CA
Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression: A double-blind randomized controlled trial$651,255
R01 · FY2024 · CA
Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression: A double-blind randomized controlled trial$692,568
R01 · FY2023 · CA